Literature DB >> 16875173

[Clinical applications of hyaluronic acid].

Ryszard Galus1, Marek Antiszko, Paweł Włodarski.   

Abstract

Hyaluronic acid (HA) is a glycosaminoglycan composed of alternating N-acetyl-D-glucosamine and D-glucuronic acid moieties. HA is an ubiquitous component of connective tissue where it forms matrix and plays an important role in the maintenance of matrix structure and water balance. The viscoelastic properties of HA derivatives and nonimmunogenicity has provided its use in a number of pharmaceutical applications. Ability of HA to create and fill space by organizing and modifying the extracellular matrix is widely used for soft tissue augmentation to limit age-related and photoinduced skin aging, but also may be used for correction of facial lipodystrophy and to prevent reccurence of hypertrophic scars or keloids. Furthermore HA may be employed as a surgical aid in ophthalmology or to reduce knee pain and joint motion in patients with osteoarthritis. In children HA may become an alternative to the open surgery for the management of vesicoureteral reflux.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16875173

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  3 in total

1.  Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles.

Authors:  Nathan S Trookman; Ronald L Rizer; Rosanne Ford; Elizabeth Ho; Vincent Gotz
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

Review 2.  Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-04-24       Impact factor: 2.744

Review 3.  Drug Carrier for Photodynamic Cancer Therapy.

Authors:  Tilahun Ayane Debele; Sydney Peng; Hsieh-Chih Tsai
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.